Effect of genetic and environmental factors on protein biomarkers for common non-communicable disease and use of personally normalized plasma protein profiles (PNPPP)

References

• Assarsson E, Lundberg M, Holmquist G, et al. (2014). Homogenous 96-Plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability. PLoS One 9:e95192
   PubMed Web of Science ®Google Scholar
• Aulchenko YS, Ripke S, Isaacs A, Van Duijn CM. (2007). GenABEL: an R library for genome-wide association analysis. Bioinformatics 23:1294–6
   PubMed Web of Science ®Google Scholar
• Band G, Marchini J. (2013). QCTOOL. Available from: http://www.well.ox.ac.uk/~gav/qctool/
   Google Scholar
• Cao Y, Depinho RA, Ernst M, Vousden K. (2011). Cancer research: past, present and future. Nat Rev Cancer 11:749–54
   PubMed Web of Science ®Google Scholar
• Chan D, Ng LL. (2010). Biomarkers in acute myocardial infarction. BMC Med 8:34
   PubMed Web of Science ®Google Scholar
• Clemitson JR, Dixon RJ, Haines S, et al. (2007). Genetic dissection of a blood pressure quantitative trait locus on rat chromosome 1 and gene expression analysis identifies SPON1 as a novel candidate hypertension gene. Circ Res 100:992–9
   PubMed Web of Science ®Google Scholar
• Durak-Nalbantic A, Dzubur A, Dilic M, et al. (2012). Brain natriuretic peptide release in acute myocardial infarction. Bosn J Basic Med Sci 12:164–8
   PubMed Web of Science ®Google Scholar
• Enroth S, Dahlbom I, Hansson T, et al. (2013). Prevalence and sensitization of atopic allergy and coeliac disease in the Northern Sweden Population Health Study. Int J Circumpolar Health 72:21403. doi: http://dx.doi.org/10.3402/ijch.v72i0.21403
   PubMed Web of Science ®Google Scholar
• Enroth S, Johansson A, Enroth SB, Gyllensten U. (2014). Strong effects of genetic and lifestyle factors on biomarker variation and use of personalized cutoffs. Nat Commun 5:4684
   PubMed Web of Science ®Google Scholar
• Freeman C, Marchini J. (2013). GTOOL. Available from: http://www.well.ox.ac.uk/~cfreeman/software/gwas/gtool.html
   Google Scholar
• Hanahan D, Weinberg RA. (2011). Hallmarks of cancer: the next generation. Cell 144:646–74
   PubMed Web of Science ®Google Scholar
• Ho JE, Chen WY, Chen MH, et al. CARDIoGRAM Consortium; CHARGE Inflammation Working Group, (2013). Common genetic variation at the IL1RL1 locus regulates IL-33/ST2 signaling. J Clin Invest 123:4208–18
   PubMed Web of Science ®Google Scholar
• Howie B, Fuchsberger C, Stephens M, et al. (2012). Fast and accurate genotype imputation in genome-wide association studies through pre-phasing. Nat Genet 44:955–9
   PubMed Web of Science ®Google Scholar
• Huang WR, Fan XX, Tang X. (2011). SiRNA targeting EGFR effectively prevents posterior capsular opacification after cataract surgery. Mol Vis 17:2349–55
   PubMed Web of Science ®Google Scholar
• Igl W, Johansson A, Gyllensten U. (2010). The Northern Swedish Population Health Study (NSPHS) – a paradigmatic study in a rural population combining community health and basic research. Rural Remote Health 10:1363
   PubMed Web of Science ®Google Scholar
• Igl W, Kamal-Eldin A, Johansson A, et al. (2013). Animal source food intake and association with blood cholesterol, glycerophospholipids and sphingolipids in a northern Swedish population. Int J Circumpolar Health 7221162. doi: http://dx.doi.org/10.3402/ijch.v72i0.21162
   PubMed Web of Science ®Google Scholar
• IMPUTE2 Reference Panels. (2012). Available from: http://mathgen.stats.ox.ac.uk/impute/impute_v2.html - reference
   Google Scholar
• Jickling GC, Ander BP, Stamova B, et al. (2013). RNA in blood is altered prior to hemorrhagic transformation in ischemic stroke. Ann Neurol 74:232–40
   PubMed Web of Science ®Google Scholar
• Jickling GC, Sharp FR. (2011). Blood biomarkers of ischemic stroke. Neurotherapeutics 8:349–60
   PubMed Web of Science ®Google Scholar
• Johansson A, Enroth S, Palmblad M, et al. (2013). Identification of genetic variants influencing the human plasma proteome. Proc Natl Acad Sci USA 110:4673–8
   PubMed Web of Science ®Google Scholar
• Johansson A, Marroni F, Hayward C, et al. (2009). Common variants in the JAZF1 gene associated with height identified by linkage and genome-wide association analysis. Hum Mol Genet 18:373–80
   PubMed Web of Science ®Google Scholar
• Juppner H. (2011). Phosphate and FGF-23. Kidney Int Suppl 121:S24–7
   PubMed Web of Science ®Google Scholar
• Kadomatsu K, Bencsik P, Gorbe A, et al. (2014). Therapeutic potential of midkine in cardiovascular disease. Br J Pharmacol 171:936–44
   PubMed Web of Science ®Google Scholar
• Kempf T, Wollert KC. (2009). Growth differentiation factor-15: a new biomarker in cardiovascular disease. Herz 34:594–9
   PubMed Web of Science ®Google Scholar
• Kendrick J, Cheung AK, Kaufman JS, et al. (2011). FGF-23 associates with death, cardiovascular events, and initiation of chronic dialysis. J Am Soc Nephrol 22:1913–22
   PubMed Web of Science ®Google Scholar
• Lundberg M, Eriksson A, Tran B, et al. (2011). Homogeneous antibody-based proximity extension assays provide sensitive and specific detection of low-abundant proteins in human blood. Nucleic Acids Res 39:e102
   PubMed Web of Science ®Google Scholar
• Maruyama K, Shiga T, Iijima M, et al. (2014). Brain natriuretic Peptide in acute ischemic stroke. J Stroke Cerebrovasc Dis 23:967–72
   PubMed Web of Science ®Google Scholar
• Mascalzoni D, Janssens AC, Stewart A, et al. (2010). Comparison of participant information and informed consent forms of five European studies in genetic isolated populations. Eur J Hum Genet 18:296–302
   PubMed Web of Science ®Google Scholar
• Nagaya N, Nishikimi T, Uematsu M, et al. (2000). Plasma brain natriuretic peptide as a prognostic indicator in patients with primary pulmonary hypertension. Circulation 102:865–70
   PubMed Web of Science ®Google Scholar
• Paget V, Legedz L, Gaudebout N, et al. (2011). N-terminal pro-brain natriuretic peptide: a powerful predictor of mortality in hypertension. Hypertension 57:702–9
   PubMed Web of Science ®Google Scholar
• Pattaro C, De Grandi A, Vitart V, et al. (2010). A meta-analysis of genome-wide data from five European isolates reveals an association of COL22A1, SYT1, and GABRR2 with serum creatinine level. BMC Med Genet 11:41
   PubMed Web of Science ®Google Scholar
• Prensner JR, Rubin MA, Wei JT, Chinnaiyan AM. (2012). Beyond PSA: the next generation of prostate cancer biomarkers. Sci Transl Med 4:127rv3
   PubMed Web of Science ®Google Scholar
• R Develpment Core Team. (2012). R: A language and environment for statistical computing. Vienna: R Foundation for Statistical Computing
   Google Scholar
• Ramos-Cejudo J, Gutierrez-Fernandez M, Rodriguez-Frutos B, et al. (2012). Spatial and temporal gene expression differences in core and periinfarct areas in experimental stroke: a microarray analysis. PLoS One 7:e52121
   PubMed Web of Science ®Google Scholar
• Ridker PM, Vaughan DE, Stampfer MJ, et al. (1993). Endogenous tissue-type plasminogen activator and risk of myocardial infarction. Lancet 341:1165–8
   PubMed Web of Science ®Google Scholar
• Salzmann J, Flitcroft D, Bunce C, et al. (1998). Brain natriuretic peptide: identification of a second natriuretic peptide in human aqueous humour. Br J Ophthalmol 82:830–4
   PubMed Web of Science ®Google Scholar
• Scacchi M, Pincelli AI, Cavagnini F. (1999). Growth hormone in obesity. Int J Obes Relat Metab Disord 23:260–71
   PubMed Web of Science ®Google Scholar
• Scholler N, Urban N. (2007). CA125 in ovarian cancer. Biomark Med 1:513–23
   PubMed Web of Science ®Google Scholar
• Takenaka H, Horiba M, Ishiguro H, et al. (2009). Midkine prevents ventricular remodeling and improves long-term survival after myocardial infarction. Am J Physiol Heart Circ Physiol 296:H462–9
   PubMed Web of Science ®Google Scholar
• Toni M, Hermida J, Goni MJ, et al. (2013). Matrix metalloproteinase-10 plays an active role in microvascular complications in type 1 diabetic patients. Diabetologia 56:2743–52
   PubMed Web of Science ®Google Scholar
• Vaidya VS, Ozer JS, Dieterle F, et al. (2010). Kidney injury molecule-1 outperforms traditional biomarkers of kidney injury in preclinical biomarker qualification studies. Nat Biotechnol 28:478–85
   PubMed Web of Science ®Google Scholar
• Van Der Bom JG, De Knijff P, Haverkate F, et al. (1997). Tissue plasminogen activator and risk of myocardial infarction. The Rotterdam Study. Circulation 95:2623–7
   PubMed Web of Science ®Google Scholar
• Vila G, Riedl M, Anderwald C, et al. (2011). The relationship between insulin resistance and the cardiovascular biomarker growth differentiation factor-15 in obese patients. Clin Chem 57:309–16
   PubMed Web of Science ®Google Scholar
• Waanders F, Van Timmeren MM, Stegeman CA, et al. (2010). Kidney injury molecule-1 in renal disease. J Pathol 220:7–16
   PubMed Web of Science ®Google Scholar
• Wardlaw JM, Murray V, Berge E, et al. (2012). Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis. Lancet 379:2364–72
   PubMed Web of Science ®Google Scholar
• Wollert KC, Kempf T. (2012). Growth differentiation factor 15 in heart failure: an update. Curr Heart Fail Rep 9:337–45
   PubMedGoogle Scholar
• World Medical Association. (2000). World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 284:3043–5
   PubMed Web of Science ®Google Scholar
• Yue C, You X, Zhao L, et al. (2010). The effects of adalimumab and methotrexate treatment on peripheral Th17 cells and IL-17/IL-6 secretion in rheumatoid arthritis patients. Rheumatol Int 30:1553–7
   PubMed Web of Science ®Google Scholar